Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K960195
    Date Cleared
    1996-04-15

    (90 days)

    Product Code
    Regulation Number
    862.1690
    Reference & Predicate Devices
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    This new immunometric assay device is a single-use Class II medical device for professional use that is designed to indicate whether a serum sample contains TSH in a concentration > 5 wW/ml.

    Device Description

    This new immunometric assay device is a single-use Class II medical device for professional use that is designed to indicate whether a serum sample contains TSH in a concentration > 5 wW/ml.

    AI/ML Overview

    Here's an analysis of the provided text, extracting the requested information about acceptance criteria and the study that proves the device meets them:

    K960195 - ThyroChek TSH Immunoassay

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria (Implicit)Reported Device Performance (ThyroChek)
    Discrimination of TSH > 5 µIU/ml vs. 5 µIU/ml from diluted samples below 5 µIU/ml (Serial Dilution):Successfully distinguished samples.
    Intra-Assay Precision (Coefficient of Variation): Reproducibility of results within the same assay run.- 4 out of 5 sets of 30 replicates showed 30 identical results.
    • 1 out of 5 sets showed 29 of 30 replicates agreed.
    • 25 samples in duplicate showed 100% agreement.
    • Implies an intra-assay coefficient of variation of less than 3%. |
      | Accuracy / Agreement with Predicate Device (Parallelism): Correctly identifying TSH levels > 5 µIU/ml and 5 µIU/ml (positive cases):**
    • Predicate identified 66 cases.
    • ThyroChek correctly identified 65 out of 66 (98.5% sensitivity).
      **For TSH 40 mlU/ml from 17 postmenopausal women) did not produce false negative/positive results or affect TSH determination. |
      | Lack of Interference: No interference from common physiological substances (glucose, uremic metabolites, lipids, hemolyzed red blood cells). | Elevated concentrations of glucose, uremic metabolites, lipids, or hemolyzed red blood cells did not interfere with device performance. |

    2. Sample Sizes Used for the Test Set and Data Provenance

    • Quantitative Recovery: Number of samples not explicitly stated, but includes samples determining 5 TSH concentrations (5.2, 5.7, 6.5, 4.1, 4.5 µlU/ml).
    • Serial Dilution: Number of samples not explicitly stated.
    • Coefficient of Variation:
      • 5 sets of 30 replicates (total 150 replicates from 5 samples).
      • 25 samples measured in duplicate (total 50 replicates from 25 samples).
    • Parallelism:
      • Total: 328 patient samples.
      • Positive (TSH > 5 µIU/ml): 66 samples (as determined by predicate).
      • **Negative (TSH 5 µIU/ml or
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1